TY - JOUR
T1 - Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
AU - Ostrowski, Jerzy
AU - Paziewska, Agnieszka
AU - Lazowska, Izabella
AU - Ambrozkiewicz, Filip
AU - Goryca, Krzysztof
AU - Kulecka, Maria
AU - Rawa, Tomasz
AU - Karczmarski, Jakub
AU - Dabrowska, Michalina
AU - Zeber-Lubecka, Natalia
AU - Tomecki, Roman
AU - Kluska, Anna
AU - Balabas, Aneta
AU - Piatkowska, Magdalena
AU - Paczkowska, Katarzyna
AU - Kierkus, Jaroslaw
AU - Socha, Piotr
AU - Lodyga, Michal
AU - Rydzewska, Grazyna
AU - Klopocka, Maria
AU - Mierzwa, Grazyna
AU - Iwanczak, Barbara
AU - Krzesiek, Elzbieta
AU - Bak-Drabik, Katarzyna
AU - Walkowiak, Jaroslaw
AU - Klincewicz, Beata
AU - Radwan, Piotr
AU - Grzybowska-Chlebowczyk, Urszula
AU - Landowski, Piotr
AU - Jankowska, Agnieszka
AU - Korczowski, Bartosz
AU - Starzynska, Teresa
AU - Albrecht, Piotr
AU - Mikula, Michal
N1 - Publisher Copyright:
© The Author(s) 2016.
PY - 2016/12/23
Y1 - 2016/12/23
N2 - Most inflammatory bowel diseases (IBDs) are classic complex disorders represented by common alleles. Here we aimed to define the genetic architecture of pediatric and adult-onset IBDs for the Polish population. A total of 1495 patients were recruited, including 761 patients with Crohn's disease (CD; 424 pediatric), 734 patients with ulcerative colitis (UC; 390 pediatric), and 934 healthy controls. Allelotyping employed a pooled-DNA genome-wide association study (GWAS) and was validated by individual genotyping. Whole exome sequencing (WES) was performed on 44 IBD patients diagnosed before 6 years of age, 45 patients diagnosed after 40 years of age, and 18 healthy controls. Altogether, out of 88 selected SNPs, 31 SNPs were replicated for association with IBD. A novel BRD2 (rs1049526) association reached significance of P = 5.2 × 10-11 and odds ratio (OR) = 2.43. Twenty SNPs were shared between pediatric and adult patients; 1 and 7 were unique to adult-onset and pediatric-onset IBD, respectively. WES identified numerous rare and potentially deleterious variants in IBD-Associated or innate immunity-Associated genes. Deleterious alleles in both groups were over-represented among rare variants in affected children. Our GWAS revealed differences in the polygenic architecture of pediatric-And adult-onset IBD. A significant accumulation of rare and deleterious variants in affected children suggests a contribution by yet unexplained genetic components.
AB - Most inflammatory bowel diseases (IBDs) are classic complex disorders represented by common alleles. Here we aimed to define the genetic architecture of pediatric and adult-onset IBDs for the Polish population. A total of 1495 patients were recruited, including 761 patients with Crohn's disease (CD; 424 pediatric), 734 patients with ulcerative colitis (UC; 390 pediatric), and 934 healthy controls. Allelotyping employed a pooled-DNA genome-wide association study (GWAS) and was validated by individual genotyping. Whole exome sequencing (WES) was performed on 44 IBD patients diagnosed before 6 years of age, 45 patients diagnosed after 40 years of age, and 18 healthy controls. Altogether, out of 88 selected SNPs, 31 SNPs were replicated for association with IBD. A novel BRD2 (rs1049526) association reached significance of P = 5.2 × 10-11 and odds ratio (OR) = 2.43. Twenty SNPs were shared between pediatric and adult patients; 1 and 7 were unique to adult-onset and pediatric-onset IBD, respectively. WES identified numerous rare and potentially deleterious variants in IBD-Associated or innate immunity-Associated genes. Deleterious alleles in both groups were over-represented among rare variants in affected children. Our GWAS revealed differences in the polygenic architecture of pediatric-And adult-onset IBD. A significant accumulation of rare and deleterious variants in affected children suggests a contribution by yet unexplained genetic components.
UR - https://www.scopus.com/pages/publications/85007079708
U2 - 10.1038/srep39831
DO - 10.1038/srep39831
M3 - Article
C2 - 28008999
AN - SCOPUS:85007079708
SN - 2045-2322
VL - 6
JO - Scientific Reports
JF - Scientific Reports
M1 - 39831
ER -